(Q37970702)

26 August 2017

title

What is different about serotype 1 pneumococci? (English)

1 reference

26 August 2017

2

1 reference

26 August 2017

Neil D Ritchie

1

1 reference

26 August 2017

Tom J Evans

series ordinal

3

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

number of pages

14

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

33-46

1 reference

A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

The dynamics of nasopharyngeal streptococcus pneumoniae carriage among rural Gambian mother-infant pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Nasopharyngeal colonization of infants in southern India with Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

THE OCCURRENCE OF CARRIERS OF DISEASE-PRODUCING TYPES OF PNEUMOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Age-specific cluster of cases of serotype 1 Streptococcus pneumoniae carriage in remote indigenous communities in Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

An Outbreak of Streptococcus pneumoniae Serotype 1 in a Closed Community in Southern Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

An outbreak of pneumococcal pneumonia in two men's shelters

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Pneumococcal serotypes in children in 4 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Observations regarding historical accounts of pneumococcal diseases due to serotypes 1 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Pediatric parapneumonic empyema, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Dynamics of penicillin-susceptible clones in invasive pneumococcal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Streptococcus pneumoniaeInfections in the Neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Invasive pneumococcal disease in England and Wales: vaccination implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Childhood empyema in North-East Scotland over the past 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Clinical features, aetiology and outcome of empyema in children in the north east of England

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Community‐acquired bacteremic pneumococcal pneumonia in children: diagnosis and serotyping by real‐time polymerase chain reaction using blood samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Tuboovarian abscess and peritonitis caused by Streptococcus pneumoniae serotype 1 in young girls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Outbreaks of serious pneumococcal disease in closed settings in the post-antibiotic era: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

INTRANASAL VIRULENCE OF PNEUMOCOCCI FOR MICE.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Structural features of polysaccharides that induce intra-abdominal abscesses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Oligoclonal CD4+ T cells promote host memory immune responses to Zwitterionic polysaccharide of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Interleukin-6 is essential for zwitterionic polysaccharide-mediated abscess formation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Interleukin-17A mediates acquired immunity to pneumococcal colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

T cell-independent antigens type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Pneumolysin: a double-edged sword during the host-pathogen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Insertion sequence 1515 in the ply gene of a type 1 clinical isolate of Streptococcus pneumoniae abolishes pneumolysin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Timing of serotype 1 pneumococcal disease suggests the need for evaluation of a booster dose

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Rapid pneumococcal evolution in response to clinical interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Virulence in Mice of Pneumococcal Clonal Types with Known Invasive Disease Potential in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

The NLRP3 Inflammasome Is Differentially Activated by Pneumolysin Variants and Contributes to Host Defense in Pneumococcal Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFMB.11.146

21 January 2018

Identifiers

DOI

10.2217/FMB.11.146

1 reference

26 August 2017

1 reference